Dr. Grace Dy, MD
Claim this profileRoswell Park Cancer Institute
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
9 reported clinical trials
14 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
2Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Grace Dy, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Osimertinib
for Non-Small Cell Lung Cancer
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back after a period of improvement (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 242 criteria
More about Grace Dy, MD
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Grace Dy, MD has experience with
- Pembrolizumab
- Nivolumab
- Atezolizumab
- CIMAvax Vaccine
- Carboplatin
- Etoposide
Breakdown of trials Grace Dy, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Skin Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Grace Dy, MD specialize in?
Grace Dy, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Grace Dy, MD currently recruiting for clinical trials?
Yes, Grace Dy, MD is currently recruiting for 5 clinical trials in Buffalo New York. If you're interested in participating, you should apply.
Are there any treatments that Grace Dy, MD has studied deeply?
Yes, Grace Dy, MD has studied treatments such as Pembrolizumab, Nivolumab, Atezolizumab.
What is the best way to schedule an appointment with Grace Dy, MD?
Apply for one of the trials that Grace Dy, MD is conducting.
What is the office address of Grace Dy, MD?
The office of Grace Dy, MD is located at: Roswell Park Cancer Institute, Buffalo, New York 14263 United States. This is the address for their practice at the Roswell Park Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.